Synovus Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,001
Closed -$208K 856
2023
Q2
$208K Sell
10,001
-164,299
-94% -$3.57M ﹤0.01% 802
2023
Q1
$4.1M Buy
174,300
+2,145
+1% +$57.6K 0.05% 219
2022
Q4
$4.81M Sell
172,155
-4,479
-3% -$115K 0.05% 192
2022
Q3
$4.12M Buy
176,634
+34,921
+25% +$1.05M 0.05% 192
2022
Q2
$4.78M Buy
141,713
+579
+0.4% +$20.3K 0.06% 177
2022
Q1
$4.93M Buy
141,134
+28,042
+25% +$959K 0.05% 187
2021
Q4
$3.44M Buy
113,092
+225
+0.2% +$7.33K 0.03% 246
2021
Q3
$3.68M Buy
112,867
+74,254
+192% +$2.38M 0.04% 217
2021
Q2
$1.13M Buy
+38,613
New +$1.27M 0.01% 406

Other funds holding OGN

Synovus Financial's OGN Position: Q3 2023 in Review

Synovus Financial sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 10,001 shares — an estimated $208K sold.

Synovus Financial first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $4.93M in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Synovus Financial reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Synovus Financial sold 10,001 Organon & Co shares in Q3 2023, an estimated $208K.
  • Synovus Financial first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Synovus Financial's Organon & Co position peaked at $4.93M in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Synovus Financial's 13F filing for Q3 2023, filed 13 Nov 2023.